MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment (Upgraded)

$38,600.00

Download PDF

  • Including Doctor Consultation and Report Explanation
  • Interrogating 270 cancer-related genes in a single test
  • Comprehensively covering 38 and 42 common cancer-related diseases in males and females respectively
  • Early detection of cancer signals and a comprehensive understanding of the risk of cancer gene mutations

Category:

Description

MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment (Upgraded)

 

HOW CANCER STARTS?

  • For a cancer to start, changes take place within the genes of a cell or a group of cells
  • It can take many years for a cell to divide and accumulate enough mutations to form a tumor
  • Cancer is the leading cause of death in Hong Kong and mainland China, and its incidence and mortality are increasing
  • Before the age of 75:

Almost 1 in 4 will attain cancer

MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment (Upgraded)

Almost 1 in 12 will die cancer

MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment (Upgraded)

 

OVER 50% CANCER CASES ARE DIAGNOSED AT LATE-STAGES OF THE DISEASES

  • Over 34,000 people are diagnosed with cancer each year in Hong Kong
  • Over 50% of cancer cases are diagnosed late
  • Mirroring incidence trends, rates increased for cancers in younger individuals

MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment (Upgraded)

 

SCREENING CTDNA IS A BETTER WAY FOR EARLY CANCER RISK ASSESSMENT

  • ctDNA is released from the tumor cell, which is dead or active, and then enters the blood.
  • As ctDNA comes from tumor cells, this is a significant biomarker for early cancer risk assessment.
  • For cancer risk assessment, we are screening the ctDNA, which has any gene mutations.

MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment (Upgraded)

 

MYGENIA® CIRCULATING TUMOR DNA (CTDNA) CANCER RISK ASSESSMENT

  • Interrogating 270 cancer-related genes in a single test
  • Comprehensively covering 38 and 42 common cancer-related diseases in males and females respectively
  • The latest OEC detection technology interrogates all the coding regions of the target genes
  • OEC detection technology covers more gene mutations related to cancer pathogenesis

 

NEW COLLECT SAMPLING METHOD – MORE CONVENIENT

MYGENIA® Circulating Tumor DNA (ctDNA) Cancer Risk Assessment (Upgraded)

 

SUITABLE FOR:

  • Unhealthy lifestyle: staying up late and sleep deprivation
  • Overweight, lack of exercise
  • Smoking, drinking alcohol and other unhealthy diet
  • Staying in highly polluted or radiologically contaminated places
  • Persons with non-communicable diseases or immunocompromised conditions
  • Persons with family history of cancer

 

Source:
* Hong Kong Anti-Cancer Society
# HKCaR

 

Instructions for use

  • Must be used on or before the expiration date
  • Please show your confirmation information, order number, registered full name and phone number for verification

 

Terms and Conditions

  • This voucher is only valid for Trinity Medical Centre.
  • The voucher must be paid on or before 30 June 2024, can be used at Central , Causeway Bay or Tsim Sha Tsui Trinity Medical Centre.
  • This voucher must be used within 90 days after purchase and this voucher is not valid after expiration.
  • This voucher is non-refundable and cannot be redeemed for full or partial cash.
  • You must bring this ticket to the front desk when you register.
  • This voucher cannot be used with any other special offers and promotions.
  • If this voucher is lost or stolen, we will not accept any liability and will not provide any reissue in such case.
  • If you have any questions, please call 2192 7022 or email tmc@trinitymedical.com.hk
  • Trinity Medical Centre reserves the right to amend the above Terms and Conditions without prior notice. In case of any disputes, Trinity Medical Centre reserves all rights for final decision.